News

More recently, a new generation of ‘atypical’ antipsychotic medication has been ... through application of DSM IV criteria during chart review and interview. Patients receiving concurrent ...
From the smaller number of randomized controlled trials that compare atypical antipsychotics, no notable pattern of differential effectiveness has emerged in favor of or against any one agent of ...
A chart review was conducted to evaluate ... mood instability, atypical ideation, and PDD. The antipsychotic was begun at a dose of 7.5 mg daily to control atypical thinking and behavior.
However, the limited differences in the direct comparison between typical and atypical groups suggest that the two classes of antipsychotics may share some common effects on brain structure ...
March 26, 2008 (Orlando, Florida) — A small chart review of 18 elderly long-term-care patients who received atypical antipsychotics found that 61% (n = 11) lost weight and only 33% (n = 6 ...
There are two main categories of antipsychotics: typical and atypical. Typical antipsychotics have been around longer and are ...
We performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and an older, conventional neuroleptic drug, haloperidol, in terms of the rate of relapse in patients with ...
Objective: To compare persistence, compliance, and psychiatric treatment costs in patients who were initiated on atypical antipsychotics. Methods: Medical and pharmacy claims data were used to ...
We conducted a population-based cohort study involving all elderly people in British Columbia to compare the short-term mortality between those prescribed a conventional antipsychotic medication and ...
Atypical antipsychotics, in comparison to first-generation antipsychotics, have a lower affinity for dopaminergic receptors and an action on some serotonin receptor subtypes (such as antagonism at ...
Recently, the Food and Drug Administration (FDA) issued an advisory stating that atypical antipsychotic medications ... hazards models were used to compare the risk of death within 180 days ...